Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$610B
| 2,986 | -8 | -0.3% | $269B |
|
| 2 |
2
Abbott
ABT
$181B
| 2,307 | +59 | +3% | $143B |
|
| 3 |
3
Medtronic
MDT
$122B
| 1,810 | +50 | +3% | $113B |
|
| 4 |
4
Danaher
DHR
$163B
| 1,633 | +49 | +3% | $121B |
|
| 5 |
5
Becton Dickinson
BDX
$52.8B
| 1,436 | +6 | +0.4% | $57.1B |
|
| 6 |
6
Stryker
SYK
$112B
| 1,400 | -6 | -0.4% | $56.8B |
|
| 7 |
7
DuPont de Nemours
DD
$17.8B
| 1,188 | +20 | +2% | $31.4B |
|
| 8 |
8
Intuitive Surgical
ISRG
$151B
| 1,153 | +104 | +10% | $72.9B |
|
| 9 |
9
Baxter International
BAX
$13.3B
| 1,098 | -37 | -3% | $34.7B |
|
| 10 |
10
Edwards Lifesciences
EW
$50.8B
| 1,083 | +35 | +3% | $41.1B |
|
| 11 |
11
Roper Technologies
ROP
$37.8B
| 941 | +34 | +4% | $38.5B |
|
| 12 |
12
Zimmer Biomet
ZBH
$18B
| 931 | -15 | -2% | $24.9B |
|
| 13 |
13
Boston Scientific
BSX
$64B
| 843 | +2 | +0.2% | $50B |
|
| 14 |
14
Labcorp
LH
$26.4B
| 810 | +11 | +1% | $16.6B |
|
| 15 |
15
Agilent Technologies
A
$49.5B
| 767 | +20 | +3% | $27.1B |
|
| 16 |
16
Quest Diagnostics
DGX
$26.4B
| 758 | +9 | +1% | $13.5B |
|
| 17 |
17
DexCom
DXCM
$33.1B
| 728 | +5 | +0.7% | $37.8B |
|
| 18 |
18
Align Technology
ALGN
$10.6B
| 664 | +32 | +5% | $22.4B |
|
| 19 |
19
ResMed
RMD
$34.1B
| 627 | +44 | +8% | $17.3B |
|
| 20 |
20
DELISTED
Hologic
HOLX
| 568 | +45 | +9% | $16.1B |
|
| 21 |
21
Steris
STE
$21.9B
| 567 | -9 | -2% | $13.7B |
|
| 22 |
22
Waters Corp
WAT
$43.6B
| 546 | +3 | +0.6% | $10.9B |
|
| 23 |
23
Teleflex
TFX
$5.43B
| 540 | +3 | +0.6% | $14.4B |
|
| 24 |
24
Alcon
ALC
$32.2B
| 538 | -14 | -3% | $13.5B |
|
| 25 |
25
Revvity
RVTY
$17.3B
| 531 | +67 | +14% | $12.8B |
|